![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
RD Spealman, J Bergman, BK Madras and KF Melia
Harvard Medical School, New England Regional Primate Research Center, Southborough, Massachusetts.
The involvement of dopamine (DA) receptor subtypes in the discriminative stimulus effects of cocaine was investigated in squirrel monkeys trained to discriminate cocaine from vehicle using a two-lever choice procedure. Lever pressing was maintained under a 10-response fixed-ratio schedule of food presentation. In substitution tests, (-)- cocaine and its high-affinity analogs 2 beta-carbomethoxy-3 beta-(4- fluorophenyl)tropane (CFT) and 2 beta-carbomethoxy-3 beta-(4- chlorophenyl)tropane (CCT) engendered dose-related increases in the proportion of cocaine-appropriate responses. Full (97-100%) substitution for the training dose of cocaine was observed with all three drugs, the rank order of potency being: CCT greater than CFT greater than cocaine. DA agonists differing in selectivity for D1 and D2 receptor subtypes [6-chloro-7,8-dihydroxy-1-phenyl-2,3,4,5- tetrahydro-[1H]-3-benzazepine (SKF 81297), 6-chloro-7,8-dihydroxy-1- phenyl-2,3,4,5-tetrahydro-3-allyl-[1H]-3- benzazepine (SKF 82958), (+)- 4-propyl-9-hydroxynapthoxazine [(+)-PHNO], quinpirole, quinelorane, (-)- 4,6,6a,7,8,-12b-hexahydro-7-methyl-indolo[4,3-ab]phen ant hridine (CY 208-243) and (-)-apomorphine] also engendered dose-related increases in cocaine-appropriate responses. However, maximally effective doses of these drugs occasioned an average of only 54 to 77% responses on the cocaine-associated lever and markedly reduced response rates. Combinations of the D1 agonist SKF 81297 and the D2 agonist (+)-PHNO did not engender a consistently higher proportion of cocaine- appropriate responses than did either drug alone.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  S. B. Caine, M. Thomsen, K. I. Gabriel, J. S. Berkowitz, L. H. Gold, G. F. Koob, S. Tonegawa, J. Zhang, and M. Xu Lack of Self-Administration of Cocaine in Dopamine D1 Receptor Knock-Out Mice J. Neurosci., November 28, 2007; 27(48): 13140 - 13150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Adewale, D. M. Platt, and R. D. Spealman Pharmacological Stimulation of Group II Metabotropic Glutamate Receptors Reduces Cocaine Self-Administration and Cocaine-Induced Reinstatement of Drug Seeking in Squirrel Monkeys J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 922 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Lee, D. M. Platt, J. K. Rowlett, A. S. Adewale, and R. D. Spealman Attenuation of Behavioral Effects of Cocaine by the Metabotropic Glutamate Receptor 5 Antagonist 2-Methyl-6-(phenylethynyl)-pyridine in Squirrel Monkeys: Comparison with Dizocilpine J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1232 - 1240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Jutkiewicz and J. Bergman Effects of Dopamine D1 Ligands on Eye Blinking in Monkeys: Efficacy, Antagonism, and D1/D2 Interactions J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1008 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W. Czoty, C. R. Ramanathan, N. H. Mutschler, A. Makriyannis, and J. Bergman Drug Discrimination in Methamphetamine-Trained Monkeys: Effects of Monoamine Transporter Inhibitors J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 720 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gasior, C. A. Paronis, and J. Bergman Modification by Dopaminergic Drugs of Choice Behavior under Concurrent Schedules of Intravenous Saline and Food Delivery in Monkeys J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 249 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Platt, J. K. Rowlett, and R. D. Spealman Dissociation of Cocaine-Antagonist Properties and Motoric Effects of the D1 Receptor Partial Agonists SKF 83959 and SKF 77434 J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 1017 - 1026. [Abstract] [Full Text]
|
|
|
|
|
|
L. L. Howell, P. W. Czoty, M. J. Kuhar, and F. I. Carrol Comparative Behavioral Pharmacology of Cocaine and the Selective Dopamine Uptake Inhibitor RTI-113 in the Squirrel Monkey J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 521 - 529. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. K. Romach, P. Glue, K. Kampman, H. L. Kaplan, G. R. Somer, S. Poole, L. Clarke, V. Coffin, J. Cornish, C. P. O'Brien, et al. Attenuation of the Euphoric Effects of Cocaine by the Dopamine D1/D5 Antagonist Ecopipam (SCH 39166) Arch Gen Psychiatry, December 1, 1999; 56(12): 1101 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Katz, T. A. Kopajtic, K. A. Myers, R. J. Mitkus, and M. Chider Behavioral Effects of Cocaine: Interactions with D1 Dopaminergic Antagonists and Agonists in Mice and Squirrel Monkeys J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 265 - 279. [Abstract] [Full Text]
|
|
|
|
|
|
D. M. Platt, D. M. Grech, J. K. Rowlett, and R. D. Spealman Discriminative Stimulus Effects of Morphine in Squirrel Monkeys: Stimulants, Opioids, and Stimulant-Opioid Combinations J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1092 - 1100. [Abstract] [Full Text]
|
|
|
|
|
|
M. R. Brandt, S. S. Negus, N. K. Mello, M. S. Furness, X. Zhang, and K. C. Rice Discriminative Stimulus Effects of the Nonpeptidic delta -Opioid Agonist SNC80 in Rhesus Monkeys J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1157 - 1164. [Abstract] [Full Text]
|
|
|
|
|
|
S. S. Negus, M. B. Gatch, and N. K. Mello Discriminative Stimulus Effects of a Cocaine/Heroin "Speedball" Combination in Rhesus Monkeys J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1123 - 1136. [Abstract] [Full Text]
|
|
|
|
|
|
J. W. Tidey and a. J. Bergman Drug Discrimination in Methamphetamine-Trained Monkeys: Agonist and Antagonist Effects of Dopaminergic Drugs J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1163 - 1174. [Abstract] [Full Text]
|
|
|
|
|
|
B. Geter-Douglass, J. L. Katz, K. Alling, J. B. Acri, and J. M. Witkin Characterization of Unconditioned Behavioral Effects of Dopamine D3/D2 Receptor Agonists J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 7 - 15. [Abstract] [Full Text]
|
|
|
|
|
|
M. A. Nader, K. A. Grant, H. M. L. Davies, R. H. Mach, and S. R. Childers The Reinforcing and Discriminative Stimulus Effects of the Novel Cocaine Analog 2beta -Propanoyl-3beta -(4-Tolyl)-Tropane in Rhesus Monkeys J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 541 - 550. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
